Changing gastric cancer treatment in the United States and the pursuit of quality

Scott A Hundahl, H. J. Wanebo

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The low incidence of gastric cancer in the US presents various quality challenges. For most US practitioners, individual experience is inadequate. Accrual to clinical trials testing new treatments can be daunting. However, through the use of nationally available clinical trials sponsored by many trial groups working in concert, and the use of national registries for treatment and outcome surveillance, a path to increased gastric cancer survival has been charted. Moreover, systems for continuous quality improvement at the institutional level are in place. Quality assurance is an increasing concern of both private and governmental groups. In this article, we summarize recent national US clinical trial findings concerning gastric cancer treatment, highlight national assessment systems for cancer outcomes, and describe what these systems tell us about the current status of gastric cancer care in the US, highlighting challenges and areas for potential improvement.

Original languageEnglish (US)
Pages (from-to)605-615
Number of pages11
JournalEuropean Journal of Surgical Oncology
Volume31
Issue number6 SPEC. ISS.
DOIs
StatePublished - Aug 2005

Fingerprint

Stomach Neoplasms
Clinical Trials
Quality Improvement
Registries
Incidence
Neoplasms

Keywords

  • Chemo-radiation
  • Gastric cancer
  • Maruyama Index
  • Outcomes
  • Quality
  • Surgery
  • Surveillance

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Changing gastric cancer treatment in the United States and the pursuit of quality. / Hundahl, Scott A; Wanebo, H. J.

In: European Journal of Surgical Oncology, Vol. 31, No. 6 SPEC. ISS., 08.2005, p. 605-615.

Research output: Contribution to journalArticle

@article{42d056bfe46247c3a98980bbef5f64ce,
title = "Changing gastric cancer treatment in the United States and the pursuit of quality",
abstract = "The low incidence of gastric cancer in the US presents various quality challenges. For most US practitioners, individual experience is inadequate. Accrual to clinical trials testing new treatments can be daunting. However, through the use of nationally available clinical trials sponsored by many trial groups working in concert, and the use of national registries for treatment and outcome surveillance, a path to increased gastric cancer survival has been charted. Moreover, systems for continuous quality improvement at the institutional level are in place. Quality assurance is an increasing concern of both private and governmental groups. In this article, we summarize recent national US clinical trial findings concerning gastric cancer treatment, highlight national assessment systems for cancer outcomes, and describe what these systems tell us about the current status of gastric cancer care in the US, highlighting challenges and areas for potential improvement.",
keywords = "Chemo-radiation, Gastric cancer, Maruyama Index, Outcomes, Quality, Surgery, Surveillance",
author = "Hundahl, {Scott A} and Wanebo, {H. J.}",
year = "2005",
month = "8",
doi = "10.1016/j.ejso.2005.02.011",
language = "English (US)",
volume = "31",
pages = "605--615",
journal = "Clinical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "6 SPEC. ISS.",

}

TY - JOUR

T1 - Changing gastric cancer treatment in the United States and the pursuit of quality

AU - Hundahl, Scott A

AU - Wanebo, H. J.

PY - 2005/8

Y1 - 2005/8

N2 - The low incidence of gastric cancer in the US presents various quality challenges. For most US practitioners, individual experience is inadequate. Accrual to clinical trials testing new treatments can be daunting. However, through the use of nationally available clinical trials sponsored by many trial groups working in concert, and the use of national registries for treatment and outcome surveillance, a path to increased gastric cancer survival has been charted. Moreover, systems for continuous quality improvement at the institutional level are in place. Quality assurance is an increasing concern of both private and governmental groups. In this article, we summarize recent national US clinical trial findings concerning gastric cancer treatment, highlight national assessment systems for cancer outcomes, and describe what these systems tell us about the current status of gastric cancer care in the US, highlighting challenges and areas for potential improvement.

AB - The low incidence of gastric cancer in the US presents various quality challenges. For most US practitioners, individual experience is inadequate. Accrual to clinical trials testing new treatments can be daunting. However, through the use of nationally available clinical trials sponsored by many trial groups working in concert, and the use of national registries for treatment and outcome surveillance, a path to increased gastric cancer survival has been charted. Moreover, systems for continuous quality improvement at the institutional level are in place. Quality assurance is an increasing concern of both private and governmental groups. In this article, we summarize recent national US clinical trial findings concerning gastric cancer treatment, highlight national assessment systems for cancer outcomes, and describe what these systems tell us about the current status of gastric cancer care in the US, highlighting challenges and areas for potential improvement.

KW - Chemo-radiation

KW - Gastric cancer

KW - Maruyama Index

KW - Outcomes

KW - Quality

KW - Surgery

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=22144431580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144431580&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2005.02.011

DO - 10.1016/j.ejso.2005.02.011

M3 - Article

C2 - 16023944

AN - SCOPUS:22144431580

VL - 31

SP - 605

EP - 615

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0748-7983

IS - 6 SPEC. ISS.

ER -